Olema Oncology Announces New Clinical Data for Palazestrant in Combination with Ribociclib to be Presented at the 2024 ESMO Breast Cancer Annual Congress
May 08, 2024 07:02 ET
|
Olema Oncology
SAN FRANCISCO, May 08, 2024 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology,” Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery,...
SpringWorks Therapeutics to Participate in the BofA Securities 2024 Health Care Conference
May 08, 2024 07:00 ET
|
SpringWorks Therapeutics, Inc.
STAMFORD, Conn., May 08, 2024 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a commercial-stage biopharmaceutical company focused on severe rare diseases and cancer, today...
Sprott Announces First Quarter 2024 Results
May 08, 2024 07:00 ET
|
Sprott Inc.
TORONTO, May 08, 2024 (GLOBE NEWSWIRE) -- Sprott Inc. (NYSE/TSX: SII) (“Sprott” or the “Company”) today announced its financial results for the quarter ended March 31, 2024. Management commentary...
Mayfair Gold Provides Update on Fenn-Gib Gold Project
May 08, 2024 07:00 ET
|
Mayfair Gold Corp.
Successful completion of Phase 6 drill programDrill results from Main, Footwall, Deformation, and Contact Zones2024 environmental field program underwayPre-feasibility study tradeoff studies underway ...
MegaWatt Metals Provides Corporate Update, Including Advancing Clean-Energy Focus Through Agreement to Acquire Uranium Property
May 08, 2024 07:00 ET
|
MegaWatt Lithium and Battery Metals Corp.
● Acquired Canada-based uranium property ● Closed non-brokered private placement Vancouver, British Columbia, May 08,...
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Blue
May 08, 2024 07:00 ET
|
Faruqi & Faruqi LLP
NEW YORK, May 08, 2024 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against bluebird bio, Inc. (“Blue” or the “Company”)...
Aura Biosciences to Participate in Upcoming Investor Conferences
May 08, 2024 07:00 ET
|
Aura Biosciences, Inc.
BOSTON, May 08, 2024 (GLOBE NEWSWIRE) -- Aura Biosciences, Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing precision immunotherapies to treat solid tumors designed to preserve...
Bio-Path Holdings to Announce First Quarter 2024 Financial Results on May 15, 2024
May 08, 2024 07:00 ET
|
Bio-Path Holdings, Inc.
HOUSTON, May 08, 2024 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ: BPTH) a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop a...
1stDibs Reports First Quarter 2024 Financial Results
May 08, 2024 07:00 ET
|
1stDibs.com, Inc.
NEW YORK, May 08, 2024 (GLOBE NEWSWIRE) -- 1stdibs.com, Inc. (NASDAQ: DIBS), a leading online marketplace for luxury design products ("1stDibs" or the "Company"), today reported financial results...
Omega Therapeutics Presents New Preclinical Data at ASGCT 2024 Demonstrating Tunable and Durable Upregulation of Gene Expression with Epigenomic Controllers
May 08, 2024 07:00 ET
|
Omega Therapeutics
Programmable epigenomic mRNA candidates enabled durable and robust upregulation of gene expression across a diverse set of gene types and regulatory mechanismsAdditional OMEGA platform capabilities...